According to Acumen Research and Consulting, the global Craniomaxillofacial (CMF) Devices market is expected to grow at noteworthy CAGR around 5.7 % throughout the forecast period and reach around US$ 3.5 billion by 2026.
The demand for craniomaxillo-facial (CMF) devices is projected to increase with minimally invasive surgery. Increased incidence and demand for effective reconstructive operations are expected to allow growth as the result of urbanisation and industrialisation.
The report provides analysis of global Craniomaxillofacial (CMF) Devices market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.
Cases of facial fractures are expected to increase mainly due to combat sports (around 80 %). Nose and teeth are the most damaged areas and need more attention in prevention actions. Kickboxing is the most harmful sport of all combat sport and the greatest number of maxillofacial traumas have taken place. This leads to an increased demand for CRI.
Moreover, increased consumer awareness is one of the major contributors to the growth of the market. In a sampling program for increasing awareness of CMF surgeries, for example, organizations such as the American Society of Craniofacial Chirurgic (ASCFS) and the International Society of Craniofacial Surgery (ISCFS).
In addition, increased geriatric population and spending on healthcare are presumed to drive demand for CMF operation over the forecast period. It is expected to provide lucrative growth opportunities for this market with the integration of state-of - the-art 3D implants in cranial reconstructive operations to enhance adoption.
Product segment of craniomaxillofacial appliances includes TMJ replacement, CMF distraction, fixation of cranial flaps, CMF platform and screw mountedness, bone graft replacement and thoracic fastening. The product segment with market share of more than 70% was led by the CMF plate and screw fastening in 2018. It's widely used in various operations, such as deformity correction, orthognatic surgery, the removal of tumors and pediatric surgery. In neurosurgery and ENT as well as in plastic surgeries, cranial flap fixing devices found application, as they are used to initiate scalp opening in craniotomy procedures and face plastic surgeries for correction of face distortions.
The development of the cranial flap fixing segment is driven by technological developments, such as the introduction of the titanium cranial attaching system, and increased efficience in device applications. Moreover, in the short term, bio-absorbable implants based on polymers are expected to become popular.
The fastest CAGR replacement TMJ devices in the forecast period are expected to occur due to the growing incidence of road and sports accidents leading to cranial and facial fractures. In prothesis jaw substitution surgery TMJ devices are used. It also supports the use of fused joints, dizzy fractures, degenerated joints, abnormalities and arthritism in orthodontic and dental operations as well as plastic operations.
These instruments help to reduce jaw pain, eat disruptions and increase the ability to open the mouth. TMJ substitution is the fastest growing segment due to an increasing number of cosmetic surgeries, such as chin increases and jaw substitution to improve the appearance of facial skin.
Because of the advantages of materials such as lower corrosiveness, ability to provide rigid fracture support, relatively low costs compared to bioabsorable counterparts and greater market penetration than other materials, the general market for the material was led by metal implants. Metals are used for CMF operations because they are less corrosive in nature and support fractures physiologically.
Titanium and its alloy, due to the benefit associated with CMF surgery such as light weight, metal inert properties, implants strength, high acceptance tissue levels and corrosion resistance, are the most commonly used metals. It is used in the reconstruction of the mandibular system.
The use of these implants eliminates the likelihood of a second surgery, necessary for metal implants, and easy body assimilation, is expected to record lucrative growing during the forecast period. The factors expected to propel market growth are technological developments in CMF operations and the associated advantages, for example self-enhanced technologies such as biocompatible, easily handled, degrading properties and reliabilities.
In addition, increasing government initiatives to raise awareness of the use of CMF surgeries to address deformations are expected in the next few years to expand the consumer base for growth in the sector.
Neurosurgery and ENT held the biggest share of revenue as of 2018 due to the increasing incidence of CSF surgery trauma and spinal disorders. Craniotomies are done to treat trauma, skull breakage, aneurysm, Parkinson's disease, brain pressure after a stroke or an injury, and to remove blood clotting from head injury. Craniotomies are performed by surgeons to gain greater access to the brain.
In addition, one of the key contributing factors to this segment growth is the adoption of the deep brain stimulation process. After inserting the electrode into deep brain stimulation, implants are used to cover the skull. The neuro-operational application of cranial implants is crystal implant and otolaryngological procedures. They help with neuro-oncology, neurovascular diseases, spinal disorders, repair of the hard mother, surgery based on the transnasal skull, deep brain stimulation, pelvic or cranial trauma and CSF management. Most commonly used for neurochirurgical use are Medpor bioabsorbable implants.
Additionally, the introduction of surgical-navigation technology for ENT procedures is expected to fuel growth over the forecast period in the market for craniomaxillofacial devices. The benefits associated with this technology are expected to boost adoption in the immediate future, such as simple use, 3D displays and virtual anatomy updates in real time.
Plastic surgery is expected to be the quickest due to increased awareness, demand and expenditure on cosmetic surgery, particularly in developing economies like the U.S. In addition, CFSD are expected to gain popularity in the coming years, which therefore supports the growth of the segment. CFSD is used for Maxillofacial Oncologic and Reconstructive Surgery (MORS).
With a market share of more than 58 percent, North America led to a rise of face and facial deformation due to increased industrialization in 2018. The impressive growth is due to the introduction of technologically advanced cranial implants, increasing demand for minimally invasive surgery, availability of advanced healthcare facilities and a high level of patient awareness.
Due to the increasing demand for ambulatory activity and the prevalence of related infections, US accounted for the largest share of revenue. Furthermore, the increased burden on the government to implement security guidelines is expected to stimulate growth over the projected period.
The key impact driving forces in Asia and Pacific are the presence of unaffected opportunities, the continued improvement of the health infrastructure, economic development, and growing patient awareness.
Global Craniomaxillofacial (CMF) Devices Market, By Product
Global Craniomaxillofacial (CMF) Devices Market, By Material
Global Craniomaxillofacial (CMF) Devices Market, By Application
Global Craniomaxillofacial (CMF) Devices Market, By Geography
The market research study on “Craniomaxillofacial (CMF) Devices Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Craniomaxillofacial (CMF) Devices market segments with market dynamics and their impact. The report also covers basic technology development policies.
The report provides an analysis of the latest industry trends from 2015 to 2026 in all sub-segment segments and forecasts revenue and volume growth on the global, the regional and country levels.
Key Players & Strategies
The industry is extremely competitive, with a restricted amount of competitors dominating. DePuy Synthes (J&J), Medtronic, Stryker and Zimmer-Biomet are among the most remarkable respondents. Because of their comprehensive consumer offers, these businesses represent an important income share in the USA. DePuy Synthes continued to introduce innovative fresh goods with a lower profile and excellent results for nurses that lead to higher income.